The PSMA-targeting Half-life Extended BiTE Therapy AMG 160 has Potent Antitumor Activity in Preclinical Models of Metastatic Castration-resistant Prostate Cancer
暂无分享,去创建一个
P. Bogner | M. Friedrich | P. Kufer | T. Raum | B. Rattel | O. Thomas | J. Wahl | A. Coxon | P. Deegen | Doris Rau | F. Aeffner | J. Bailis | Olivier Nolan-Stevaux | Michael Z. Liao | Shyun Li | Katja Matthes | Tobias Raum | Petra Deegen